MWA vs RFA for the Treatment of Moderate-sized Benign Thyroid Nodules

Thyroid nodule is a common condition that affects up to 60% of the population. There is an estimated 10% lifetime probability of developing a thyroid nodule. Although most thyroid nodules are benign, up to 10-15% can enlarge to cause compressive symptoms including neck pressure and discomfort, dysphagia, dyspnea, and dysphonia. The conventional treatment for these benign but problematic nodules has been thyroidectomy. Although generally a low risk operation, thyroidectomy is associated with some risk for recurrent laryngeal nerve injury, bleeding, infection, and need for thyroid hormone supple

Trial Details

NCT ID
NCT06426563
Phase
NA
Sponsor
The University of Hong Kong
Status
RECRUITING
Cancer Type
Thyroid Cancer
Interventions
  • Ablation treatment of thyroid nodule
Locations (sample)
  • Hong Kong, Hong Kong, Hong Kong|22.27832,114.17469

Key Eligibility Criteria

  • Adult patients \>/=18 years of age
  • Nodule maximal diameter ≥2cm and nodule volume \<20ml
  • Nodule being predominantly solid (≥80% solid)
  • Confirmed benign nature of nodules, either by : two benign fine needle biopsies, with the most recent biopsy performed within 1 year of enrollment …

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Thyroid Cancer Trials on Trialify →